GlassScriptPhysician profile
Jennifer Rucker
NPI 1205887205
$2,015.04
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,166 · 2022: $809 · 2023: $39.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $511.59 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $240.30 | 2021-2022 | |
| Abbott Laboratories | $189.85 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $174.80 | 2021 | |
| Almatica Pharma LLC | $143.59 | 2021-2022 | |
| Pfizer INC. | $141.52 | 2021-2023 | |
| Baudax Bio INC. | $100.14 | 2021 | |
| Collegium Pharmaceutical, INC. | $96.62 | 2021 | |
| Boston Scientific Corporation | $72.03 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $69.85 | 2021 | |
| Ibsa Pharma INC. | $63.83 | 2021-2022 | |
| Vertos Medical, INC. | $45.08 | 2021 | |
| Arbor Pharmaceuticals, INC. | $30.40 | 2021 | |
| Grt US Holding, INC. | $28.90 | 2022 | |
| Relievant Medsystems, INC. | $26.06 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $20.41 | 2023 | Ztlido |
| Novartis Pharmaceuticals Corporation | $17.32 | 2021 | |
| Medtronic, INC. | $16.79 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.47 | 2021 | |
| Amgen INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Rucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.